Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K221235
    Manufacturer
    Date Cleared
    2022-07-28

    (90 days)

    Product Code
    Regulation Number
    N/A
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Misonix Inc. neXus Ultrasonic System is intended for the fragmentation, emulsification and aspiration of both soft and hard (i.e., bone) tissue.

    The indications for use for the Standard Handpiece in combination with BoneScalpel and SonicOne OR probe kit accessory configurations, the SonaStar®long and short handpieces in combination with SonaStar probe kit accessory configurations, the BoneScalpel AccessTM handpiece with BoneScalpel AccessTM probe kit accessory configurations, and the SonaStar Elite Handpiece with probe kit accessory configurations are listed below.

    Standard Handpiece with BoneScalpel Probe Kits

    Indicated for use in the fragmentation, emulsification of soft and hard (e.g., bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    • · Thoracic Surgery
      Limited pulmonary resection such as segmentectomical subsegmentectomies and metastatectornes.

    · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.

    Standard Handpiece with SonicOne Probe Kits

    Indicated for use in the fragmentation and aspiration of soft and hard tissue (i.e. bone) in the following surgical specialty:

    · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.

    · Plastic and Reconstructive Surgery

    neXus SonaStar Handpieces with SonaStar Probe Kits

    · Indicated for use in the fragmentation, emulsification of both soft and hard (i.e. bone) tissue in the following surgical specialties:
    · Neurosurgery

    · Gastrointestinal and Affiliated Organ Surgery - including removal of benign or malignant tumors or other unwanted tissue, including hepatic parenchyma, in open or laparoscopic procedures, hepatic resection, tumor resection, lobectomy or trisegmentectomy, or removal of tissue during liver allotransplantation and donor hepatectomy

    · Urological Surgery - including removal of renal parenchyma during nephrectomy or partial nephrectomy

    · Plastic and Reconstructive Surgery

    · General Surgery - including removal of benign or malignant tumors or other unwanted tissue in open or minimally invasive general surgical procedures

    • · Orthopedic Surgery
    • · Gynecological Surgery except as contraindicated for uterine fibroids.
    • · Thoracic Surgery

    · Laparoscopic Surgery - including removal of hepatic parenchyma in laparoscopic hepatic resection, lobectomy or trisegmentectomy, in laparoscopic donor hepatectomy or laparoscopic cholecystectomy or laparoscopic pancreatic jejunostomy, or pancreatectomy, or laparoscopic appendectorny, laparoscopic colon resection or laparoscopic partial gastrectomy

    · Thoracoscopic Surgery

    The SonaStar Handpieces may also be combined with electrosurgery using optional RF surgery interface components.

    Bone Scalpel Access Handpiece with BoneScalpel Access Probe Kits

    Indicated for use in the fragmentation of soft and hard (e.g.: bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    • · Thoracic Surgery
      Limited pulmonary resection such as segmentectomical subsegmentectomies and metastatectomies.

    SonaStar Elite Handpiece with SonaStar Elite Probe Kits

    Indicated for use in the fragmentation of soft and hard (e.g., bone) tissue in the following surgical specialties:

    • · Neurosurgery
      • Gastrointestinal and Affiliated Organ Surgery – including removal of benign or malignant tumors or other unwanted tissue, including hepatic parenchyma, in open or laparoscopic procedures, hepatic resection, tumor resection, lobectomy or trisegmentectomy, or removal of tissue during liver allotransplantation and donor hepatectomy

    • · Urological Surgery including removal of renal parenchyma during nephrectomy or partial nephrectomy

    • · Plastic and Reconstructive Surgery

    • · General Surgery including removal of benign or malignant tumors or other unwanted tissue in open or minimally invasive general surgical procedures

    • · Orthopedic Surgery

    • · Gynecological Surgery except as contraindicated for uterine fibroids.

    • · Thoracic Surgery

    · Laparoscopic Surgery - including removal of hepatic parenchyma in laparoscopic hepatic resection, lobectomy or trisegmentectomy, in laparoscopic donor hepatectomy or laparoscopic cholecystectomy or laparoscopic pancreatic jejunostomy, or pancreatectomy, or laparoscopic appendectorny, laparoscopic colon resection or laparoscopic partial
    · Thoracoscopic Surgery

    The system may also be combined with electrosurgery using optional RF surgery interface components.

    Device Description

    The neXus Ultrasonic Surgical Aspirator System is intended for fragmentation, emulsification and aspiration of both soft and hard (i.e., bone) tissue. The system includes a generator housed inside the console. A reusable handpiece is plugged directly into the front panel of the console.

    The generator and handpiece are compatible with various single use disposable "probes" which are selected and attached to the handpiece by the end user. An irrigation unit provides sterile irrigant to the operative site. An aspiration system removes the fragmented, emulsified material and waste liquids from the operative site.

    Accessories include a wireless footswitch, various probe tip combinations, sterilization trays, probe covers, assembly & disassembly wrenches, irrigation tubing sets, and waste collection canisters.

    AI/ML Overview

    The provided text is a 510(k) Premarket Notification from the FDA for a medical device. It focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study to prove the device meets specific acceptance criteria for a novel AI/software component.

    Therefore, the document does not contain the information requested in your prompt regarding acceptance criteria and a study proving a device meets these criteria, especially concerning AI/software performance metrics like sensitivity, specificity, or reader improvement with AI assistance.

    The document primarily focuses on:

    • Device Description and Intended Use: Detailing the neXus Ultrasonic Surgical Aspirator System and its various configurations for fragmentation, emulsification, and aspiration of soft and hard tissue in different surgical specialties.
    • Technological Comparison: Comparing the subject device's features (Compatible Handpieces, Principle of Operation, Reusable/Disposable Accessories, Cleaning & Sterilization, Electrosurgery, Console features, etc.) to a predicate device (CUSA Clarity Ultrasonic Aspirator System, K200774).
    • Performance Data: Presenting evidence for biocompatibility, sterility/shelf life, electrical safety, electromagnetic compatibility (EMC), and software verification/validation.
      • Biocompatibility: Mentions testing against ISO 10993 standards (Cytotoxicity, Sensitization, Irritation/Intracutaneous Reactivity, Acute Systemic Toxicity, Pyrogenicity).
      • Sterility and Shelf Life: Describes testing for single-use and reusable components and accelerated/real-time aging studies for shelf life.
      • Electrical Safety and EMC: Confirms testing to IEC 60601 standards.
      • Software Verification and Validation: States that V&V testing was conducted as per FDA guidance for "major" level of concern software.
      • Bench Testing: Lists tests performed, including Acoustic Intensity, Applied Part Temperature, Probe Vibration, Soft Tissue Performance, and Probe Life Testing.
    • Absence of Animal or Clinical Data: Explicitly states that animal and clinical studies were "Not applicable" as they were "not necessary to establish the substantial equivalence of this device."

    In summary, this document is a regulatory submission for substantial equivalence based on technological and performance similarities to an existing device, not a performance study for a new AI/software feature with defined acceptance criteria and clinical outcome measures.

    Ask a Question

    Ask a specific question about this device

    K Number
    K212060
    Manufacturer
    Date Cleared
    2021-12-13

    (165 days)

    Product Code
    Regulation Number
    N/A
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Misonix Inc. neXus® Ultrasonic System is intended for the fragmentation, emulsification and aspiration of both soft and hard (i.e.bone) tissue.

    The indications for use for the Standard Handpiece in combination with BoneScalpel® OR probe kit accessory configurations and the indications for the SonaStar® long and short handpiece in combination with SonaStar® probe kit accessory configurations are listed below.

    Standard Handpiece with BoneScalpel Probe Kits

    Indicated for use in the fragmentation of soft and hard (e.g.: bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or maligmant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    • · Thoracic Surgery
      Limited pulmonary reception such as segmetectomies, nonanatomical subsegmentectomies and metastatectomies.

    · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.

    Standard Handpiece with SonicOne Probe Kits

    Indicated for use in the fragmentation of soft and hard tissue (i.e. bone) in the following surgical specialty: · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement. · Plastic and Reconstructive Surgery

    Long SonaStar Handpiece & Short SonaStar Handpiece with SonaStar Probe Kits

    Indicated for use in the fragmentation, emulsification of both soft and hard (i.e. bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery General Surgery
    • · Orthopedic Surgery
    • · Gynecological Surgery except as contraindicated for uterine fibroids.
    • · Thoracic Surgery
    • · Laparoscopic Surgery
    • · Thoracoscopic Surgery

    The SonaStar Handpieces may also be combined with electrosurgery using optional RF surgery interface components.

    Bone Scalpel Access Handpiece with BoneScalpel Access Probe Kit

    Indicated for use in the fragmentation of soft and hard (e.g.: bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    · Thoracic Surgery

    Limited pulmonary reception such as segmetectomies, nonanatomical subsegmentectomies and metastatectomies.

    Device Description

    The neXus Ultrasonic Surgical Aspirator System is intended for fragmentation, emulsification and aspiration of both soft and hard (i.e., bone) tissue. The system includes a generator housed inside the console. A reusable handpiece is plugged directly into the front panel of the console.

    The generator and handpiece are compatible with various single use disposable "probes" which are selected and attached to the handpiece by the end user. An irrigation unit provides sterile irrigant to the operative site. An aspiration system removes the fragmented, emulsified material and waste liquids from the operative site.

    Accessories include a wireless footswitch, various probe tip combinations, sterilization trays, probe covers, assembly & disassembly wrenches, irrigation tubing sets, and waste collection canisters.

    AI/ML Overview

    The acceptance criteria and supporting study details for the Misonix Inc. neXus Ultrasonic Surgical Aspirator System (K212060) are described below based on the provided text.

    Based on the provided document, the device described is an ultrasonic surgical aspirator system, and the filing is a 510(k) premarket notification for substantial equivalence. This type of filing generally focuses on comparing a new device to an existing predicate device rather than presenting novel clinical efficacy studies with specific acceptance criteria directly comparable to new AI/diagnostic technologies. Therefore, the information provided does not directly align with a typical acceptance criteria table and study design for AI-based diagnostic devices.

    However, I can extract the relevant performance data and study types conducted to demonstrate substantial equivalence, which serves as the "acceptance criteria" for a 510(k) submission.

    1. Table of Acceptance Criteria and Reported Device Performance

    For a 510(k) submission, "acceptance criteria" are typically defined by demonstrating that the new device is as safe and effective as a legally marketed predicate device, and does not raise new questions of safety or effectiveness. The performance data presented are primarily to show that the technological characteristics and performance are substantially equivalent.

    Acceptance Criteria (Demonstrated Equivalence to Predicate K190160)Reported Device Performance (Misonix neXus Ultrasonic Surgical Aspirator System K212060)
    Biocompatibility: Meet ISO 10993 standards for biological safety.Passed: Testing included Cytotoxicity (ISO 10993-5), Irritation (ISO 10993-10), Sensitization (ISO 10993-10), Acute Systemic Cytotoxicity (ISO 10993-11), and Pyrogenicity (USP <151>).
    Sterilization & Shelf Life: Single-use components are sterile; reusable components can be sterilized. Maintain sterile barrier and efficacy for a defined shelf life.Single-use components (Probe Kits) are provided sterile: Sterilization method unchanged from predicate. Reusable components (handpiece parts) are end-user cleaned and sterilized: Validated instructions for use provided, including expected use life. Shelf Life: Accelerated testing demonstrated acceptable 37-month shelf life. Real-time aging studies for 13 months were provided, with 37-month real-time studies planned.
    Electrical Safety & EMC: Comply with relevant IEC 60601 standards.Passed: Complied with IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 + A1:2012, and IEC 60601-1-2:2014. No significant differences related to compliance with these standards between the subject and predicate devices. IEC 60601-2-2:2017 was not applicable to the subject device (but was for the predicate with electrosurgery).
    Software Verification & Validation: Software functions as intended and does not pose undue risk.Passed: Software verification and validation (V&V) testing was conducted, and documentation was provided as recommended by FDA guidance for "major" level of concern software.
    Bench Testing: Demonstrate functional equivalence to the predicate in key performance areas.Passed: Tests performed included: Ultrasound Performance Testing, Acoustic Intensity Testing, Applied Part Temperature Testing (Normal and Abnormal Operating Conditions), Hard Tissue Performance Testing, and Thermal Testing of Simulated Bone Tissue on BoneScalpel Access Handpiece and Tips. The document states these tests "support the claim of substantial equivalence," implying the results were comparable or within acceptable ranges relative to the predicate.

    Study Details:

    The provided document describes studies conducted to support a 510(k) submission, which aims to demonstrate substantial equivalence to a predicate device (K190160). This is not equivalent to a performance study for an AI diagnostic device.

    • 2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

      • The document primarily discusses bench testing, biocompatibility testing, electrical safety, EMC, and software V&V. These are engineering and laboratory tests, not clinical studies in the context of diagnostic device performance.
      • No "test set" of patient data (images, clinical records) is mentioned.
      • The provenance of materials for bench/biocompatibility testing (e.g., simulated bone, biological samples) is not specified.
    • 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not applicable. This device is not an AI diagnostic algorithm requiring expert "ground truth" for a test set of patient data. The studies involve laboratory measurements and engineering assessments.
    • 4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • Not applicable. No expert adjudication of a test set is described.
    • 5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No MRMC study was conducted. This device is an ultrasonic surgical aspirator, a therapeutic surgical tool, not a diagnostic AI system assisting human readers.
    • 6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

      • Not applicable. This is a hardware surgical device, not an algorithm. Performance tests evaluate the device's physical outputs and safety parameters.
    • 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • For biocompatibility: Ground truth is defined by the biological response of cells/tissue to the device materials, evaluated against established ISO standards.
      • For electrical safety/EMC: Ground truth is defined by compliance with published international safety standards (e.g., IEC 60601 series).
      • For software V&V: Ground truth is defined by the software specifications and requirements.
      • For bench testing: Ground truth is defined by engineering specifications, physical measurements, and comparison to the predicate device's known performance characteristics.
    • 8. The sample size for the training set:

      • Not applicable. This is not an AI/machine learning device that uses a "training set."
    • 9. How the ground truth for the training set was established:

      • Not applicable, as there is no training set mentioned for this device.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1